- Report
- December 2020
- 47 Pages
France
From €4830EUR$4,995USD£4,121GBP
- Report
- December 2020
- 147 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5797EUR$5,995USD£4,946GBP
- Report
- July 2023
- 132 Pages
Global
From €919EUR$950USD£784GBP
- Report
- May 2022
- 210 Pages
Global
From €5578EUR$5,769USD£4,759GBP
- Report
- May 2022
- 314 Pages
Global
From €5578EUR$5,769USD£4,759GBP
Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon is a type of cardiovascular device used to treat coronary artery disease. It is a minimally invasive procedure that involves the insertion of a balloon-tipped catheter into the coronary artery. The balloon is then inflated to widen the artery and improve blood flow. PTCA balloons are typically made of polyethylene or polyurethane and are available in a variety of sizes and shapes. They are used in conjunction with other devices such as stents and guidewires to ensure optimal results.
The PTCA Balloon market is a rapidly growing segment of the cardiovascular device industry. It is driven by the increasing prevalence of coronary artery disease, technological advancements, and the growing demand for minimally invasive treatments. The market is highly competitive, with a number of companies offering a wide range of products.
Some of the major players in the PTCA Balloon market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, and B. Braun Melsungen AG. Show Less Read more